In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 24th, 2009 | 29 | Yes |
Popular Name: N-[5-[(5-tert-butyloxazol-2-yl)methylsulfanyl]thiazol-2-yl]-3,4-dimethoxy-benzamide N-[5-[(5-tert-butyloxazol-2-yl)m…
None
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.32 | 7.07 | -18.06 | 1 | 7 | 0 | 86 | 433.555 | 8 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CDK2-1-E | Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 50 | 0.35 | Binding ≤ 10μM |
VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1900 | 0.28 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 50 | 0.35 | Binding ≤ 1μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 50 | 0.35 | Binding ≤ 10μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 1900 | 0.28 | Binding ≤ 10μM |
Description | Species |
---|---|
Activation of ATR in response to replication stress | |
Activation of the pre-replicative complex | |
CDK-mediated phosphorylation and removal of Cdc6 | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin E associated events during G1/S transition | |
DNA Damage/Telomere Stress Induced Senescence | |
EPHA-mediated growth cone collapse | |
Factors involved in megakaryocyte development and platelet production | |
G0 and Early G1 | |
G2 Phase | |
Integrin cell surface interactions | |
Meiotic recombination | |
Neurophilin interactions with VEGF and VEGFR | |
Orc1 removal from chromatin | |
p53-Dependent G1 DNA Damage Response | |
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
Regulation of APC/C activators between G1/S and early anaphase | |
SCF(Skp2)-mediated degradation of p27/p21 | |
Senescence-Associated Secretory Phenotype (SASP) | |
VEGF binds to VEGFR leading to receptor dimerization | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation |
No pre-computed analogs available. Try a structural similarity search.